Loading...

Lippo

DB:LIP
Snowflake Description

Mediocre balance sheet with moderate growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
LIP
DB
HK$2B
Market Cap
  1. Home
  2. DE
  3. Consumer Retailing
Company description

Lippo Limited, an investment holding company, primarily engages in food, and property investment and development businesses. The last earnings update was 118 days ago. More info.


Add to Portfolio Compare Print
LIP Share Price and Events
7 Day Returns
-3.4%
DB:LIP
-0.8%
Europe Consumer Retailing
0.8%
DE Market
1 Year Returns
-16.3%
DB:LIP
0.7%
Europe Consumer Retailing
-4.5%
DE Market
LIP Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Lippo (LIP) -3.4% -0.3% 12.7% -16.3% -36.2% -6.8%
Europe Consumer Retailing -0.8% -0.2% 0.1% 0.7% -2.7% -9.5%
DE Market 0.8% 6.9% 8.1% -4.5% 10.4% 13.9%
1 Year Return vs Industry and Market
  • LIP underperformed the Consumer Retailing industry which returned 0.7% over the past year.
  • LIP underperformed the Market in Germany which returned -4.5% over the past year.
Price Volatility
LIP
Industry
5yr Volatility vs Market

LIP Value

 Is Lippo undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Lippo. This is due to cash flow or dividend data being unavailable. The share price is €0.345.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Lippo's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Lippo's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:LIP PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2018-09-30) in HKD HK$-0.64
SEHK:226 Share Price ** SEHK (2019-04-25) in HKD HK$3.3
Europe Consumer Retailing Industry PE Ratio Median Figure of 32 Publicly-Listed Consumer Retailing Companies 19.44x
Germany Market PE Ratio Median Figure of 424 Publicly-Listed Companies 20.1x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Lippo.

DB:LIP PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= SEHK:226 Share Price ÷ EPS (both in HKD)

= 3.3 ÷ -0.64

-5.14x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Lippo is loss making, we can't compare its value to the Europe Consumer Retailing industry average.
  • Lippo is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does Lippo's expected growth come at a high price?
Raw Data
DB:LIP PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -5.14x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
39.6%per year
Europe Consumer Retailing Industry PEG Ratio Median Figure of 24 Publicly-Listed Consumer Retailing Companies 1.52x
Germany Market PEG Ratio Median Figure of 268 Publicly-Listed Companies 1.57x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Lippo, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Lippo's assets?
Raw Data
DB:LIP PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2018-09-30) in HKD HK$18.98
SEHK:226 Share Price * SEHK (2019-04-25) in HKD HK$3.3
Europe Consumer Retailing Industry PB Ratio Median Figure of 41 Publicly-Listed Consumer Retailing Companies 1.55x
Germany Market PB Ratio Median Figure of 574 Publicly-Listed Companies 1.87x
DB:LIP PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= SEHK:226 Share Price ÷ Book Value per Share (both in HKD)

= 3.3 ÷ 18.98

0.17x

* Primary Listing of Lippo.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Lippo is good value based on assets compared to the Europe Consumer Retailing industry average.
X
Value checks
We assess Lippo's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Consumer Retailing industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Consumer Retailing industry average (and greater than 0)? (1 check)
  5. Lippo has a total score of 1/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

LIP Future Performance

 How is Lippo expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover Lippo, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
39.6%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Lippo expected to grow at an attractive rate?
  • Lippo's earnings growth is expected to exceed the low risk savings rate of 0.2%.
Growth vs Market Checks
  • Lippo's earnings growth is expected to exceed the Germany market average.
  • Unable to compare Lippo's revenue growth to the Germany market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
DB:LIP Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:LIP Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts 39.6%
Europe Consumer Retailing Industry Earnings Growth Rate Market Cap Weighted Average 12%
Europe Consumer Retailing Industry Revenue Growth Rate Market Cap Weighted Average 3.8%
Germany Market Earnings Growth Rate Market Cap Weighted Average 11.8%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.8%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:LIP Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in HKD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:LIP Future Estimates Data
Date (Data in HKD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
DB:LIP Past Financials Data
Date (Data in HKD Millions) Revenue Cash Flow Net Income *
2018-09-30 2,566 -27 -317
2018-06-30 2,540 -196 -110
2018-03-31 2,514 -365 96
2017-12-31 2,506 -368 78
2017-09-30 2,505 -371 54
2017-06-30 2,588 -78 155
2017-03-31 2,670 215 256
2016-12-31 2,714 453 222
2016-09-30 2,758 691 188
2016-06-30 3,307 357 9
2016-03-31 3,857 24 -170
2015-12-31 3,926 -220 306

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Lippo's earnings are expected to grow significantly at over 20% yearly.
  • Unable to determine if Lippo is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:LIP Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (6 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Lippo Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:LIP Future Estimates Data
Date (Data in HKD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
DB:LIP Past Financials Data
Date (Data in HKD Millions) EPS *
2018-09-30 -0.64
2018-06-30 -0.22
2018-03-31 0.19
2017-12-31 0.16
2017-09-30 0.11
2017-06-30 0.31
2017-03-31 0.52
2016-12-31 0.45
2016-09-30 0.38
2016-06-30 0.02
2016-03-31 -0.34
2015-12-31 0.62

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Lippo will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Lippo's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Europe market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Europe market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Lippo has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

LIP Past Performance

  How has Lippo performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Lippo's growth in the last year to its industry (Consumer Retailing).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Lippo does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Lippo's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Lippo's 1-year growth to the Europe Consumer Retailing industry average as it is not currently profitable.
Earnings and Revenue History
Lippo's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Lippo Company Filings, last reported 6 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:LIP Past Revenue, Cash Flow and Net Income Data
Date (Data in HKD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2018-09-30 2,565.94 -316.70 752.78
2018-06-30 2,540.17 -110.34 750.70
2018-03-31 2,514.40 96.03 748.61
2017-12-31 2,505.76 77.91 756.39
2017-09-30 2,504.87 53.89 771.18
2017-06-30 2,587.63 154.93 792.55
2017-03-31 2,670.39 255.96 813.92
2016-12-31 2,714.31 221.85 836.16
2016-09-30 2,758.24 187.73 858.40
2016-06-30 3,307.46 8.98 879.87
2016-03-31 3,856.69 -169.76 901.35
2015-12-31 3,925.65 306.09 949.54
2015-09-30 3,994.62 798.75 997.74
2015-06-30 3,484.41 771.30 1,020.07
2015-03-31 2,974.20 743.85 1,042.41
2014-12-31 3,934.52 239.65 1,016.60
2014-09-30 4,894.84 -264.56 990.79
2014-06-30 5,813.42 -76.19 986.95
2014-03-31 6,732.00 112.17 983.12
2013-03-31 2,828.69 -8.00 924.17
2012-12-31 428.91 73.58 236.94
2012-09-30 384.60 -42.38 219.83
2012-06-30 1,504.26 62.69 541.39

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Lippo has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Lippo has efficiently used its assets last year compared to the Europe Consumer Retailing industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Lippo improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Lippo's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Consumer Retailing industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Lippo has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

LIP Health

 How is Lippo's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Lippo's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Lippo is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Lippo's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Lippo's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 1.4x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Lippo Company Filings, last reported 6 months ago.

DB:LIP Past Debt and Equity Data
Date (Data in HKD Millions) Total Equity Total Debt Cash & Short Term Investments
2018-09-30 13,812.88 2,775.78 2,403.14
2018-06-30 13,812.88 2,775.78 2,403.14
2018-03-31 15,187.81 2,480.86 3,620.77
2017-12-31 15,187.81 2,480.86 3,620.77
2017-09-30 14,758.26 2,028.39 3,821.91
2017-06-30 14,758.26 2,028.39 3,821.91
2017-03-31 14,214.74 2,018.40 3,219.65
2016-12-31 14,214.74 2,018.40 3,219.65
2016-09-30 14,607.44 1,062.01 4,028.20
2016-06-30 14,607.44 1,062.01 4,028.20
2016-03-31 14,500.32 1,288.92 3,763.24
2015-12-31 14,474.20 1,288.92 3,763.24
2015-09-30 14,214.68 1,534.08 3,888.47
2015-06-30 14,214.68 1,534.08 3,888.47
2015-03-31 15,094.51 1,797.08 4,981.68
2014-12-31 15,094.51 1,797.08 4,981.68
2014-09-30 14,800.92 1,812.69 4,865.16
2014-06-30 14,800.92 1,812.69 4,865.16
2014-03-31 15,482.25 1,340.53 4,452.51
2013-03-31 15,855.05 3,082.17 3,136.64
2012-12-31 15,206.42 3,069.12 2,684.18
2012-09-30 15,206.42 3,069.12 2,684.18
2012-06-30 14,956.02 2,437.81 1,642.75
  • Lippo's level of debt (20.1%) compared to net worth is satisfactory (less than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (14.1% vs 20.1% today).
  • Operating cash flow is negative therefore debt is not well covered.
  • Lippo is making a loss, therefore interest payments are not well covered by earnings.
X
Financial health checks
We assess Lippo's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Lippo has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

LIP Dividends

 What is Lippo's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
2.42%
Current annual income from Lippo dividends.
If you bought €2,000 of Lippo shares you are expected to receive €48 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Lippo's pays a higher dividend yield than the bottom 25% of dividend payers in Germany (1.44%).
  • Lippo's dividend is below the markets top 25% of dividend payers in Germany (3.67%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:LIP Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Europe Consumer Retailing Industry Average Dividend Yield Market Cap Weighted Average of 34 Stocks 3.7%
Germany Market Average Dividend Yield Market Cap Weighted Average of 326 Stocks 3%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.8%
Germany Bottom 25% Dividend Yield 25th Percentile 1.4%
Germany Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:LIP Future Dividends Estimate Data
Date (Data in HK$) Dividend per Share (annual) Avg. No. Analysts
DB:LIP Past Annualized Dividends Data
Date (Data in HK$) Dividend per share (annual) Avg. Yield (%)
2018-06-27 0.080 2.636
2017-06-29 0.080 1.766
2016-11-29 0.130 2.748
2016-07-28 0.130 2.764
2016-06-29 0.130 2.729
2015-07-30 0.130 3.073
2015-06-29 0.130 2.997
2014-07-30 0.130 2.883
2014-06-30 0.130 2.901
2013-07-30 0.080 1.935
2013-06-27 0.080 2.067
2013-03-27 0.000 0.000
2012-09-27 0.060 1.640
2012-08-16 0.060 1.854
2012-03-30 0.040 1.374
2011-03-31 0.020 0.721
2010-09-29 0.000 0.000
2010-08-31 0.000 0.000
2010-04-29 0.040 1.663
2010-04-12 0.040 1.543
2009-09-15 0.040 1.495

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Dividends per share have increased over the past 10 years.
Current Payout to shareholders
What portion of Lippo's earnings are paid to the shareholders as a dividend.
  • The company is paying a dividend however it is incurring a loss.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Lippo's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.8%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Lippo afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Lippo has a total score of 2/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

LIP Management

 What is the CEO of Lippo's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
John Lee
COMPENSATION HK$4,150,000
AGE 69
CEO Bio

Mr. Lee Luen-Wai, also known as John, BBS, FCA, JP serves as Principal at Go Capital & EOC. Mr. Lee has been the Chief Executive Officer of Lippo China Resources Limited since March 25, 2011. Mr. Lee has been the Chief Executive Officer of Hongkong Chinese Limited since March 25, 2011. He has been the Managing Director of Lippo Limited since 1991 and also serves as its Chief Executive Officer. He serves as the Managing Director of Lippo Asia Limited. Mr. Lee was a Partner of Price Waterhouse (now, PricewaterhouseCoopers) in Hong Kong from 1978 to 1990. He has an extensive Corporate Finance and Capital Market experience and has experience working with family offices in Asia. He has been Non-Executive Non-Independent Chairman of Healthway Medical Corporation Limited since August 2, 2017. He serves as an Executive Director of Lippo Limited and MEDCO Holdings Inc. He has been an Executive Director of Lippo China Resources Limited since 1992 and Hongkong Chinese Limited since 1992. He has been a Director of HKCB Bank Holding Company Ltd. since 1992. He served as an Independent Non-Executive Director at New World Development Company Limited since August 30, 2004, UMP Healthcare Holdings Limited since November 6, 2015 and New World China Land Limited from December 7, 2004 to September 01, 2016. He serves as a Director of LCR, First Tower, Greenroot Limited and of HKCL Holdings. He served as a Non-Executive & Non-Independent Director of Auric Pacific Group Limited from September 3, 1999 to February 23, 2006. Mr. Lee served as a Non-Executive Director of Export & Industry Bank, Inc. (EIB) until December 13, 2011. He served as a Director at Asia Now Resources Corp. from November 12, 2010 to June 12, 2012. He served as a Non-Executive Director of Overseas Union Enterprise Ltd. (OUE Limited) from July 19, 2006 to December 2006. Mr. Lee is active in public services particularly in the healthcare sector. He serves as Member on a number of Hong Kong Government Boards and Committees including the Broadcasting Authority, Advisory Council on Food and Environmental Hygiene, Appeal Board on Closure Orders (Immediate Health Hazard), Council of the City University of Hong Kong and Solicitors Disciplinary Tribunal Panel. He serves as the Chairman of the Board of Trustees of the Hospital Authority Provident Fund Scheme and the chairman of the Queen Elizabeth Hospital Governing Committee. In addition, Mr. Lee serves as a member of the Appeal Boards Panel (Education). Mr. Lee was awarded the Bronze Bauhinia Star and the Justice of Peace by the HKSAR Government. He has been a Fellow Member of the Association of Chartered Certified Accountants in January 1980 and Fellow of the Hong Kong Society of Accountants in April 1981. Mr. Lee is a Fellow Member of the Hong Kong Institute of Certified Public Accountants and an Associate Member of The Institute of Chartered Accountants in England and Wales. He is an Honorary Fellow of the City University of Hong Kong and a Justice of Peace in Hong Kong. Mr. Lee graduated from Metropolitan College.

CEO Compensation
  • John's compensation has increased whilst company is loss making.
  • John's remuneration is about average for companies of similar size in Germany.
Management Team Tenure

Average tenure of the Lippo management team in years:

7.8
Average Tenure
  • The average tenure for the Lippo management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Stephen Tjondro Riady

TITLE
Chairman & Executive President
COMPENSATION
HK$17M
AGE
58
TENURE
4.3 yrs

John Lee

TITLE
MD, CEO & Executive Director
COMPENSATION
HK$4M
AGE
69

Alex Au

TITLE
Chief Financial Officer
TENURE
7.8 yrs

Davy Lee

TITLE
Company Secretary
TENURE
28 yrs
Board of Directors Tenure

Average tenure and age of the Lippo board of directors in years:

16
Average Tenure
68
Average Age
  • The average tenure for the Lippo board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors

John Lee

TITLE
MD, CEO & Executive Director
COMPENSATION
HK$4M
AGE
69

Mochtar Riady

TITLE
Honorary Chairman
AGE
88
TENURE
16 yrs

Stephen Tjondro Riady

TITLE
Chairman & Executive President
COMPENSATION
HK$17M
AGE
58
TENURE
28.3 yrs

Victor Yung

TITLE
Independent Non Executive Director
COMPENSATION
HK$1M
AGE
64
TENURE
14.6 yrs

King Fai Tsui

TITLE
Independent Non-Executive Director
COMPENSATION
HK$1M
AGE
68
TENURE
14.6 yrs

Edwin Neo

TITLE
Independent Non-Executive Director
COMPENSATION
HK$1M
AGE
68
TENURE
17.1 yrs

Jark Lee

TITLE
Non-Executive Director
COMPENSATION
HK$230K
AGE
78
TENURE
4.1 yrs

Leon Chan

TITLE
Non Executive Director
COMPENSATION
HK$1M
AGE
62
TENURE
22.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess Lippo's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Lippo has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

LIP News

Simply Wall St News

LIP Company Info

Description

Lippo Limited, an investment holding company, primarily engages in food, and property investment and development businesses. The company operates through Property Investment, Property Development, Treasury Investment, Securities Investment, Corporate Finance and Securities Broking, Food Businesses, Healthcare Services, Banking Business, Mineral Exploration and Extraction, and Other segments. It distributes customer food and non-food products; and operates and manages restaurants and food courts, as well as manufactures and retails food products. The company is also involved in the development, letting, sale, and resale of real estate properties; and provides management, asset management, and commercial consulting services, as well as owns motor yachts. In addition, it invests in money markets; deals in securities and financial assets available-for-sale; and offers securities and futures brokerage, commodities brokerage, investment banking, underwriting, and other related advisory services, as well as provides commercial and retail banking services, and other related financial services. Further, the company engages in the exploration, extraction, and processing of minerals; money lending activities; and provision of property, project, and fund management services, as well as healthcare management services; and involved in hotel, corporate finance, and securities and treasury investment businesses. It operates in Hong Kong, Macau, Mainland China, Singapore, the United States, Malaysia, and internationally. The company is based in Central, Hong Kong. Lippo Limited is a subsidiary of Lippo Capital Limited.

Details
Name: Lippo Limited
LIP
Exchange: DB
Founded:
HK$186,273,587
493,154,032
Website: http://www.lippoltd.com.hk
Address: Lippo Limited
Tower Two,
40th Floor,
Central,
Hong Kong
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
SEHK 226 Ordinary Shares The Stock Exchange of Hong Kong Ltd. HK HKD 01. Jul 1993
DB LIP Ordinary Shares Deutsche Boerse AG DE EUR 01. Jul 1993
Number of employees
Current staff
Staff numbers
1,930
Lippo employees.
Industry
Food Distributors
Consumer Retailing
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/04/25 20:35
End of day share price update: 2019/04/25 00:00
Last estimates confirmation: 2018/06/27
Last earnings filing: 2018/12/28
Last earnings reported: 2018/09/30
Last annual earnings reported: 2018/03/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.